Remed Co.Ltd (302550) - Total Assets
Based on the latest financial reports, Remed Co.Ltd (302550) holds total assets worth ₩54.74 Billion KRW (≈ $37.10 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Remed Co.Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Remed Co.Ltd - Total Assets Trend (2017–2025)
This chart illustrates how Remed Co.Ltd's total assets have evolved over time, based on quarterly financial data. See net assets of Remed Co.Ltd for net asset value and shareholders' equity analysis.
Remed Co.Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Remed Co.Ltd's total assets of ₩54.74 Billion consist of 51.5% current assets and 48.5% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 15.7% |
| Accounts Receivable | ₩6.41 Billion | 11.9% |
| Inventory | ₩6.93 Billion | 12.9% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩81.35 Million | 0.2% |
| Goodwill | ₩1.47 Billion | 2.7% |
Asset Composition Trend (2017–2025)
This chart illustrates how Remed Co.Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Remed Co.Ltd.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Remed Co.Ltd's current assets represent 51.5% of total assets in 2025, an increase from 42.0% in 2017.
- Cash Position: Cash and equivalents constituted 15.7% of total assets in 2025, up from 0.0% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2017.
- Asset Diversification: The largest asset category is inventory at 12.9% of total assets.
Remed Co.Ltd Competitors by Total Assets
Key competitors of Remed Co.Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
|
Germany | €2.83 Billion |
|
Novocure Ltd
NASDAQ:NVCR
|
USA | $787.93 Million |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥3.71 Billion |
|
Bactiguard Holding AB (publ)
ST:BACTI-B
|
Sweden | Skr537.34 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
Remed Co.Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.75 | 2.21 | 8.73 |
| Quick Ratio | 2.09 | 1.70 | 8.08 |
| Cash Ratio | 0.00 | 0.21 | 1.70 |
| Working Capital | ₩18.35 Billion | ₩17.14 Billion | ₩44.49 Billion |
Remed Co.Ltd - Advanced Valuation Insights
This section examines the relationship between Remed Co.Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.15 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -8.7% |
| Total Assets | ₩53.91 Billion |
| Market Capitalization | $54.78 Million USD |
Valuation Analysis
Below Book Valuation: The market values Remed Co.Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Remed Co.Ltd's assets decreased by 8.7% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Remed Co.Ltd (2017–2025)
The table below shows the annual total assets of Remed Co.Ltd from 2017 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩53.91 Billion ≈ $36.53 Million |
-8.73% |
| 2024-12-31 | ₩59.06 Billion ≈ $40.03 Million |
+7.27% |
| 2023-12-31 | ₩55.06 Billion ≈ $37.31 Million |
-29.52% |
| 2022-12-31 | ₩78.13 Billion ≈ $52.94 Million |
+1.20% |
| 2021-12-31 | ₩77.20 Billion ≈ $52.32 Million |
+5.08% |
| 2020-12-31 | ₩73.47 Billion ≈ $49.79 Million |
+110.23% |
| 2019-12-31 | ₩34.95 Billion ≈ $23.68 Million |
+62.45% |
| 2018-12-31 | ₩21.51 Billion ≈ $14.58 Million |
+70.81% |
| 2017-12-31 | ₩12.59 Billion ≈ $8.53 Million |
-- |
About Remed Co.Ltd
Remed Co.,Ltd. engages in the manufacture and supply of medical devices worldwide. The company offers transcranial magnetic stimulator, a technology for the treatment of disorders, such as stroke, autism, dementia, Parkinson's disease, developmental disorders, and tinnitus. It also offers neuro magnetic stimulation systems for helping blood circulation, treating pain, neurons, regenerating cells,… Read more